98 related articles for article (PubMed ID: 9566711)
21. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
22. [Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma].
Song B; Zhu JY; Liu J; Wang ZH; Shi Y; Lü LY; Zheng Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):97-100. PubMed ID: 18315909
[TBL] [Abstract][Full Text] [Related]
23. Rflp analysis of the L-myc oncogene in head and neck-cancer - relationship study with susceptibility and disease progression.
Millon R; Muller D; Velten M; Doffoel S; Eber M; Engelmann A; Bronner G; Flesch H; Methlin G; Abecassis J
Int J Oncol; 1995 Jan; 6(1):237-42. PubMed ID: 21556529
[TBL] [Abstract][Full Text] [Related]
24. Different susceptibility of each L-myc genotype to esophageal cancer risk factors.
Kumimoto H; Hamajima N; Nishizawa K; Nishimoto Y; Matsuo K; Harada H; Shinoda M; Hatooka S; Ishizaki K
Jpn J Cancer Res; 2001 Jul; 92(7):735-9. PubMed ID: 11473723
[TBL] [Abstract][Full Text] [Related]
25. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer.
Tamai S; Sugimura H; Caporaso NE; Resau JH; Trump BF; Weston A; Harris CC
Int J Cancer; 1990 Sep; 46(3):411-5. PubMed ID: 1975565
[TBL] [Abstract][Full Text] [Related]
26. Close correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human lung cancer to the lymph nodes and other organs.
Kawashima K; Shikama H; Imoto K; Izawa M; Naruke T; Okabayashi K; Nishimura S
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2353-6. PubMed ID: 2895475
[TBL] [Abstract][Full Text] [Related]
27. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in genitourinary cancers.
Kakehi Y; Taki Y; Yoshida O
Urol Int; 1991; 47 Suppl 1():86-9. PubMed ID: 1683040
[TBL] [Abstract][Full Text] [Related]
28. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
30. Distinguishing between monoclonal rearrangements and allelic forms of the immunoglobulin lambda light chain constant region genes. Significance in the diagnosis of non-Hodgkin's lymphoma.
Saueracker EA; Kay PH; Spagnolo DV
Diagn Mol Pathol; 1992 Jun; 1(2):109-17. PubMed ID: 1364171
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
32. Activation of MYCN in a case of non-Hodgkin's lymphoma.
Finnegan MC; Hammond DW; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Aug; 18(5-6):511-4. PubMed ID: 8528061
[TBL] [Abstract][Full Text] [Related]
33. L-MYC allelotype in renal cell carcinoma.
Presti JC; Hinckley J; Reuter VE
Cancer Genet Cytogenet; 1996 May; 88(1):66-8. PubMed ID: 8630982
[TBL] [Abstract][Full Text] [Related]
34. L-myc proto-oncogene alleles and susceptibility to hepatocellular carcinoma.
Taylor JA; Bell DA; Nagorney D
Int J Cancer; 1993 Jul; 54(6):927-30. PubMed ID: 8392982
[TBL] [Abstract][Full Text] [Related]
35. c-MYC gene abnormalities in high grade and centroblastic-centrocytic non-Hodgkins lymphoma.
Levasseur M; Middleton PG; Angus B; Proctor SJ; Norden J; Howard MR
Leuk Lymphoma; 1995 Jun; 18(1-2):131-6. PubMed ID: 8580815
[TBL] [Abstract][Full Text] [Related]
36. Familial Hodgkin's and non-Hodgkin's lymphoma: different patterns in first-degree relatives.
Siebert R; Louie D; Lacher M; Schluger A; Offit K
Leuk Lymphoma; 1997 Nov; 27(5-6):503-7. PubMed ID: 9477132
[TBL] [Abstract][Full Text] [Related]
37. HLA class II alleles in Japanese patients with non-Hodgkin's lymphoma.
Nathalang O; Tatsumi N; Hino M; Yamane T; Sriphaisal T
Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):556-60. PubMed ID: 11289020
[TBL] [Abstract][Full Text] [Related]
38. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.
Tefre T; Børresen AL; Aamdal S; Brøgger A
Br J Cancer; 1990 Jun; 61(6):809-12. PubMed ID: 1973618
[TBL] [Abstract][Full Text] [Related]
39. L-myc restriction fragment length polymorphism and histological pattern of invasion in lung adenocarcinoma.
Suzuki H; Yamashiro K
Oncol Rep; 2002; 9(2):345-7. PubMed ID: 11836605
[TBL] [Abstract][Full Text] [Related]
40. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
